We are able to interpolate and collect twenty-six available fundamental indicators for BioPharma Credit PLC, which can be compared to its peers. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of BioPharma Credit to be traded at 1.08 in 90 days. Key indicators impacting BioPharma Credit's financial strength include:
Understanding current and past BioPharma Credit Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioPharma Credit's financial statements are interrelated, with each one affecting the others. For example, an increase in BioPharma Credit's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioPharma Credit's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioPharma Credit PLC. Check BioPharma Credit's Beneish M Score to see the likelihood of BioPharma Credit's management manipulating its earnings.
You should never invest in BioPharma Credit without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioPharma Stock, because this is throwing your money away. Analyzing the key information contained in BioPharma Credit's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioPharma Credit Key Financial Ratios
There are many critical financial ratios that BioPharma Credit's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioPharma Credit PLC reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining BioPharma Credit's current stock value. Our valuation model uses many indicators to compare BioPharma Credit value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioPharma Credit competition to find correlations between indicators driving BioPharma Credit's intrinsic value. More Info.
BioPharma Credit PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.62 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioPharma Credit PLC is roughly 1.62 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioPharma Credit's earnings, one of the primary drivers of an investment's value.
BioPharma Credit PLC Systematic Risk
BioPharma Credit's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioPharma Credit volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on BioPharma Credit PLC correlated with the market. If Beta is less than 0 BioPharma Credit generally moves in the opposite direction as compared to the market. If BioPharma Credit Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioPharma Credit PLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioPharma Credit is generally in the same direction as the market. If Beta > 1 BioPharma Credit moves generally in the same direction as, but more than the movement of the benchmark.
BioPharma Credit PLC Total Assets Over Time
BioPharma Credit Thematic Clasifications
BioPharma Credit PLC is part of Banks investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. All money banks and credit services. Large and small money and credit banks and credit services
This theme covers All money banks and credit services. Large and small money and credit banks and credit services. Get More Thematic Ideas
BioPharma Credit June 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioPharma Credit help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioPharma Credit PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioPharma Credit PLC based on widely used predictive technical indicators. In general, we focus on analyzing BioPharma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioPharma Credit's daily price indicators and compare them against related drivers.
When running BioPharma Credit's price analysis, check to measure BioPharma Credit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPharma Credit is operating at the current time. Most of BioPharma Credit's value examination focuses on studying past and present price action to predict the probability of BioPharma Credit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPharma Credit's price. Additionally, you may evaluate how the addition of BioPharma Credit to your portfolios can decrease your overall portfolio volatility.